For instance, treatment of PDA cells with recombinant TNF-α increased EGFR expression from carcinoma cells (54), while in another study recombinant TNF-α promoted the growth of Panc02 tumors in mice but inhibited KPC cell growth (55). The gene discussed is EGFR; the disease is Patent ductus arteriosus.